Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 26, 2024
September 27, 2024
3a1b0e14-f87e-4c72-b198-baa24f196e9a
Related Documents
Clinical Drug Interaction Studies With Combined Oral Contraceptives Guidance for Industry: Guidance for Industry
Guidance DocumentJune 8, 2023Center for Drug Evaluation and Research
Providing Over-the-Counter Monograph Submissions in Electronic Format
Guidance DocumentJuly 25, 2024Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics: Guidance for Industry
Guidance DocumentJune 14, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.